Through the collaboration, Multus will harness the speed and accuracy of New Wave Biotech’s AI software to expand the production of its products at convenient prices. The software will help the growth media specialist create virtual experimentation on thousands of processes, leveraging real-life data for continual improvements. The AI eliminates unviable processes, accelerates R&D, lowers development costs, and ultimately improves costs, explains Multus.